Talis Biomedical Corp
Change company Symbol lookup
Select an option...
TLIS Talis Biomedical Corp
X United States Steel Corp
WM Waste Management Inc
CAG Conagra Brands Inc
SIRI Sirius XM Holdings Inc
K Kellogg Co
F Ford Motor Co
CPB Campbell Soup Co
T AT&T Inc
AA Alcoa Corp
Go

Health Care : Health Care Equipment & Supplies | Small Cap Growth
Company profile

Talis Biomedical Corporation is engaged in transforming diagnostic testing by developing and commercializing products that are designed to enable molecular testing for infectious diseases and other conditions at the point of care. The Company is engaged in developing the Talis One system, a cloud-enabled molecular diagnostic platform. The Talis One system consists of compact instrument, single-use test cartridges and software that is designed to support a central cloud database, which work together and are designed to provide central laboratory levels of accuracy and be operated by an untrained user. It is also focused on developing Talis One assay kits for respiratory infections, and infections related to women's health and sexually transmitted infections (STIs). It is also developing influenza A and influenza B tests to be included as part of a respiratory panel with its COVID-19 assay (Respiratory Panel), as well as exploring adding a respiratory syncytial virus (RSV) test.

Price
Delayed
$0.8401
Day's Change
0.0051 (0.61%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.88
Day's Low
0.8372
Volume
(Light)

Today's volume of 19,876 shares is on pace to be much lighter than TLIS's 10-day average volume of 260,696 shares.

19,876

Display:

Providers:

UpdateCancel
6 providers
May 10, 2022
Talis Biomedical Announces First Quarter 2022 Financial Results

EQNX::TICKER_START (NasdaqGM:TLIS), EQNX::TICKER_END Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the...(Globe Newswire)

April 26, 2022
Talis Biomedical to Announce First Quarter 2022 Financial Results on May 10, 2022

Talis Biomedical Corporation ("TLIS"), a company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today announced that it will report first...(Globe Newswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.